MTOR and prostate cancer: Another report also showed an ACAT1-dependent CE-rich LD accumulation in prostate cancer, specifically in cases with deleted PTEN and an activated phosphoinositide 3-kinase / protein kinase B / mechanistic target of rapamycin (PI3K/AKT/mTOR) axis 3.